Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”
LITTLETON, Colo., Dec. 11, 2023 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing disorders (including mild to severe obstructive sleep apnea (OSA)), is excited to announce “Empowering Women to Champion Airway”, a pioneering event that will transcend international boundaries and unite prominent women in the medical and dental fields to shed light on the pivotal role of airway health in human well-being.
Related news for (VVOS)
- Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update
- Vivos Therapeutics Secures Medicare Approval for VidaSleep Oral Appliance
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/01/25 08:00 AM
- 24/7 Market News Snapshot 01 July, 2025 – Vivos Therapeutics, Inc. Common Stock (NASDAQ:VVOS)
- Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance